Ginkgo Bioworks Holdings Inc, based in Boston, Massachusetts, specializes in cell programming to revolutionize the production of various products. By manipulating cells, they create novel ...

Ginkgo Bioworks, the once-high-flying Boston life sciences firm, said it has notified 158 employees that they will be laid off and expects to announce another batch of layoffs next week.

Ginkgo Bioworks has been busy, announcing not just one but three acquisitions and the creation of a network backed by 25 partners that will offer ‘end-to-end’ services to R&D clients.

Shares of Ginkgo Bioworks Holdings (NYSE:DNA) fell in the premarket on Friday after the cell platform company scheduled a ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

In a recent transaction disclosed by Ginkgo Bioworks Holdings, Inc. (NYSE:DNA), Chief Accounting Officer Steven P. Coen reported selling shares of the company's Class A common... In a recent ...

Ginkgo Bioworks (DNA) announced a subcontract of up to $9.4M awarded in partnership with Carnegie Mellon University to develop bioelectronic ...

Reshma Shetty is the president, chief operating officer, and cofounder of Ginkgo Bioworks, which went public in 2021 in a merger with a so-called blank-check company that generated more than $1.6 ...

For leading one of the region’s most intriguing public companies. Jason Kelly is the cofounder and CEO of Ginkgo Bioworks, a company that aims to program cells like computers. Ginkgo’s ...

Dey, Aiyesha, Jonas Heese, Suraj Srinivasan, and Annelena Lobb. "Ginkgo Bioworks vs. Scorpion Capital: The Debate Over Related-Party Revenues." Harvard Business School Case 123-037, October 2022.

What's Going On With Ginkgo Bioworks Stock This Week? Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here's a look at what's going on.

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial ...